Purohit Paresh Kumar相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens.

通过类似尼龙搭扣的密度依赖性靶向肿瘤相关碳水化合物抗原，实现安全、抗免疫抑制的泛癌免疫疗法。

影响因子:42.5

doi:10.1016/j.cell.2025.09.001

Zhou Raymond W, Purohit Paresh Kumar, Kim Jai Hyun, Lee Sung-Uk, Burshteyn Nicole, Tifrea Delia, Cordon Andres, Grigorian Ani, Newton Barbara L, Edwards Robert A, Demetriou Michael

免疫/内分泌

发表日期：2025

文献求助收藏

Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.

TRAIL/TNFSF10 在 VHL 缺陷型肾细胞癌中的合成必需性

doi:10.1101/2025.05.29.621197

Wang Xuechun, Duong Loan, Qin Yujing, Parrotta Rossella, Purohit Paresh Kumar, Fang Yihao, Liu Guoqiang, He Jianping, Wen Jiling, Liu Yan, Zhang Yuting, Zhao Junling, Schafer Zachary T, Xuemin Lu, Szegezdi Eva, Lu Xin

细胞生物学

发表日期：2025

文献求助收藏

Mitochondrial microRNA (MitomiRs) in cancer and complex mitochondrial diseases: current status and future perspectives

线粒体微RNA（MitomiRs）在癌症和复杂线粒体疾病中的作用：现状与展望

期刊:Cellular and Molecular Life Sciences

影响因子:6.2

doi:10.1007/s00018-020-03670-0

Purohit, Paresh Kumar; Saini, Neeru

发表日期：2021

文献求助收藏

MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells

miR-195通过靶向线粒体融合蛋白-2调控乳腺癌细胞中的线粒体功能。

期刊:RNA Biology

影响因子:3.4

doi:10.1080/15476286.2019.1600999

Purohit, Paresh Kumar; Edwards, Ruairidh; Tokatlidis, Kostas; Saini, Neeru

细胞生物学

发表日期：2019

文献求助收藏